ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2 (Q34316094)
scientific article published on September 23, 2010
Language:
(P31) (Q13442814)
(P50) (Q90622273)
(P304) 9402-9412
(P407) (Q1860)
(P433) 22
(P478) 70
(P577) Thursday, September 23, 2010
(P921) (Q181600)
(Q61643320)
(Q128581)
(P953) https://cancerres.aacrjournals.org/content/canres/70/22/9402.full.pdf
http://cancerres.aacrjournals.org/cgi/content/abstract/70/22/9402
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20864510/pdf/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20864510/?tool=EBI
https://europepmc.org/articles/PMC2982862
https://europepmc.org/articles/PMC2982862?pdf=render
https://doi.org/10.1158/0008-5472.can-10-1199
https://aacrjournals.org/cancerres/article-pdf/70/22/9402/2644933/9402.pdf
(P1433) (Q326097)
(P1476) "ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2" (language: en)
(P2093) Hong-Wu Chen
Ekaterina V. Kalashnikova
Alexey S. Revenko
Abigael T. Gemo
Nicolas P. Andrews
Clifford G. Tepper
June X. Zou
Robert D. Cardiff
Alexander D. Borowsky
(P2860) (Q37726336)
(Q39745095)
(Q24644185)
(Q37618468)
(Q35007385)
(Q38350039)
(Q34013708)
(Q38352075)
(Q39843631)
(Q34286419)
(Q34024643)
(Q39874727)
(Q34925977)
(Q37352430)
(Q37098829)
(Q40167355)
(Q38358546)
(Q37038629)
(Q36898979)
(Q30493310)
(Q36811130)
(Q34714877)
(Q38429076)
(Q24300315)
(Q36707456)
(Q35757521)
(Q35191588)
(Q35630217)
(Q34717365)
(Q33234978)
(Q29615526)
(Q29615523)
(Q33831109)
(Q34345868)
(Q34268216)
(Q24672969)
(Q33186821)
(Q27860945)
(Q27860732)
(Q27860709)
(Q28032461)
(Q33967586)
(Q28245902)
(Q50335771)
(Q46076249)
(Q50666703)
(Q44811326)
(Q51929705)
(Q57165894)
(Q33362164)
other details
description scientific article published on September 23, 2010

External Links